rs6534369

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_145207.3(AFG2A):​c.1527C>T​(p.Leu509Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0214 in 1,613,388 control chromosomes in the GnomAD database, including 1,261 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.053 ( 522 hom., cov: 32)
Exomes 𝑓: 0.018 ( 739 hom. )

Consequence

AFG2A
NM_145207.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0470

Publications

4 publications found
Variant links:
Genes affected
AFG2A (HGNC:18119): (AFG2 AAA ATPase homolog A) This gene encodes a member of the ATPase associated with diverse activities family, whose members are defined by a highly conserved ATPase domain. Members of this family participate in diverse cellular processes that include membrane fusion, DNA replication, microtubule severing, and protein degradation. The protein encoded by this gene has a putative mitochondrial targeting sequence and has been proposed to function in maintenance of mitochondrial function and integrity during mouse spermatogenesis. Allelic variants in this gene have been associated with epilepsy, hearing loss, and cognitive disability syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
AFG2A Gene-Disease associations (from GenCC):
  • microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 4-122947301-C-T is Benign according to our data. Variant chr4-122947301-C-T is described in ClinVar as Benign. ClinVar VariationId is 448460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.047 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.153 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AFG2ANM_145207.3 linkc.1527C>T p.Leu509Leu synonymous_variant Exon 9 of 16 ENST00000274008.5 NP_660208.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AFG2AENST00000274008.5 linkc.1527C>T p.Leu509Leu synonymous_variant Exon 9 of 16 1 NM_145207.3 ENSP00000274008.3
AFG2AENST00000422835.2 linkn.1569C>T non_coding_transcript_exon_variant Exon 9 of 15 1
AFG2AENST00000675612.1 linkc.1524C>T p.Leu508Leu synonymous_variant Exon 9 of 17 ENSP00000502453.1
AFG2AENST00000674886.1 linkn.1589C>T non_coding_transcript_exon_variant Exon 9 of 11

Frequencies

GnomAD3 genomes
AF:
0.0534
AC:
8111
AN:
152008
Hom.:
520
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.156
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0283
Gnomad ASJ
AF:
0.0242
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.0454
GnomAD2 exomes
AF:
0.0210
AC:
5259
AN:
251000
AF XY:
0.0182
show subpopulations
Gnomad AFR exome
AF:
0.161
Gnomad AMR exome
AF:
0.0141
Gnomad ASJ exome
AF:
0.0235
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00407
Gnomad NFE exome
AF:
0.0148
Gnomad OTH exome
AF:
0.0170
GnomAD4 exome
AF:
0.0180
AC:
26365
AN:
1461264
Hom.:
739
Cov.:
31
AF XY:
0.0168
AC XY:
12223
AN XY:
726934
show subpopulations
African (AFR)
AF:
0.164
AC:
5502
AN:
33454
American (AMR)
AF:
0.0162
AC:
725
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0251
AC:
656
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39674
South Asian (SAS)
AF:
0.00132
AC:
114
AN:
86204
European-Finnish (FIN)
AF:
0.00487
AC:
260
AN:
53396
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5766
European-Non Finnish (NFE)
AF:
0.0158
AC:
17610
AN:
1111584
Other (OTH)
AF:
0.0234
AC:
1413
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1527
3053
4580
6106
7633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0534
AC:
8127
AN:
152124
Hom.:
522
Cov.:
32
AF XY:
0.0522
AC XY:
3879
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.156
AC:
6471
AN:
41434
American (AMR)
AF:
0.0283
AC:
432
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0242
AC:
84
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4822
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10602
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0148
AC:
1007
AN:
68014
Other (OTH)
AF:
0.0449
AC:
95
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
349
699
1048
1398
1747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0292
Hom.:
697
Bravo
AF:
0.0612
Asia WGS
AF:
0.0110
AC:
38
AN:
3478
EpiCase
AF:
0.0152
EpiControl
AF:
0.0153

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 26, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
5.8
DANN
Benign
0.73
PhyloP100
0.047
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6534369; hg19: chr4-123868456; API